Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Switzerland-based Novartis will disband its cell and gene therapy unit, incorporating the division's operations into other areas of the company, reported Reuters. The restructuring will eliminate 120 positions,but most of the employees will be reassigned to new roles within the…
Chocolate is not the only thing Nestlé has on its radar. The Swiss company will buy Phagenesis, a Britain-based medical device maker, for an undisclosed amount. The acquisition represents Nestlé's aim to shift more focus away from the food industry…
Reston, Va.-based Practice Greenhealth unveiled its Greenhealth Cost of Ownership Calculator Wednesday, a free tool that compares the initial costs and long-term savings of medical equipment and supplies.
Here are the four latest medical devices or drugs approved by the U.S. Food and Drug Administration.
Forget the age of the Internet. Whether the healthcare industry realizes it or not, we have now entered the age of theInternet of Things(IoT). Life as we know it is being transformed by the increased, virtual communication among machines.
Jean-Claude Saghbini
Expensive drug-coated stents may hold no long-term benefits over traditional bare-metal versions of the device, according to a study published Tuesday in the New England Journal of Medicine.
The U.S. Food and Drug Administration recently approved Siemens Healthineers' Somatom Drive computed tomography system for use in pediatrics, cardiology, oncology, and emergency medicine.
Mylan recently unveiled a $300 generic version of its EpiPen medication following controversy over the high price of the life-saving treatment. While consumers will pay less for the new unbranded EpiPen, Mylan could actually make more money from the generic…
The U.S. Food and Drug Administration on Tuesday approved Novartis' biosimilar drug Erelzi.
Theranos withdrew its request to gain emergency-use authorization from the FDA for its Zika blood test, according to the Wall Street Journal. An FDA inspection earlier this month found that the company did not have proper patient safety protocols in…